by Ketamine Greater Boston | Mar 1, 2021 | KETAMINE FOR DEPRESSION
The psychedelic sector has been attracting the attention of investors, and research has increased due to the acceptance and decriminalization of these drugs. Ketamine, specifically, has been a targeted focus for investments in alternative medicine. Ketamine clinics...
by Ketamine Greater Boston | Feb 11, 2021 | KETAMINE FOR DEPRESSION
Ketamine infusion therapy has become a popular remedy for treatment-resistant depression, anxiety, PTSD and other psychiatric conditions. Traditional drugs often take weeks or even months to start working, whereas ketamine’s results are almost instantaneous....
by Ketamine Greater Boston | Jan 25, 2021 | KETAMINE FOR DEPRESSION
When we take a step back and look at all the research that is being conducted around the use of ketamine for depression, it is absolutely remarkable. It seems as though each and every day a new facet of the drug is being put under a microscope. With this being said,...
by Ketamine Greater Boston | Jan 11, 2021 | KETAMINE FOR DEPRESSION
Much of the research—so far—about the impact of the Covid-19 pandemic on mental health has been focused on healthcare workers and the general public. However, new studies are taking a deeper look at the mental health impact on individuals with COVID-19. Early findings...
by Ketamine Greater Boston | Jan 3, 2021 | KETAMINE FOR DEPRESSION
In early 2019, the FDA approved esketamine (marketed as Spravato™) as an additional therapy option for the management of treatment-resistant depression. Like its parent compound, ketamine, Spravato aids in the restoration of synaptic connections in the brain, which is...
Recent Comments